+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Anti-Obesity Drugs Market Research Reports

Anti-obesity Drugs Market Report 2026-2036 - Product Thumbnail Image

Anti-obesity Drugs Market Report 2026-2036

  • Report
  • January 2026
  • 400 Pages
  • Global
From
Anti-Obesity Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Anti-Obesity Drugs Market - Global Forecast 2026-2032

  • Report
  • August 2026
  • 195 Pages
  • Global
From
Anti-Obesity Drugs - Global Strategic Business Report - Product Thumbnail Image

Anti-Obesity Drugs - Global Strategic Business Report

  • Report
  • August 2026
  • 121 Pages
  • Global
From
From
From
From
Anti-Obesity Drug Market - Forecast from 2026 to 2031 - Product Thumbnail Image

Anti-Obesity Drug Market - Forecast from 2026 to 2031

  • Report
  • January 2026
  • 146 Pages
  • Global
From
Lifestyle Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Lifestyle Drugs Market - Global Forecast 2026-2032

  • Report
  • August 2026
  • 193 Pages
  • Global
From
From
Topiramate Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Topiramate Drugs Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 198 Pages
  • Global
From
Topiramate Tablets Market - Global Forecast 2026-2032 - Product Thumbnail Image

Topiramate Tablets Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 180 Pages
  • Global
From
Body Fat Reduction Market - Global Forecast 2026-2032 - Product Thumbnail Image

Body Fat Reduction Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 192 Pages
  • Global
From
GLP-1 Analogues Market - Global Strategic Business Report - Product Thumbnail Image

GLP-1 Analogues Market - Global Strategic Business Report

  • Report
  • August 2026
  • 474 Pages
  • Global
From
Liraglutide and Semaglutide - Global Strategic Business Report - Product Thumbnail Image

Liraglutide and Semaglutide - Global Strategic Business Report

  • Report
  • August 2026
  • 451 Pages
  • Global
From
Lifestyle Drugs - Global Strategic Business Report - Product Thumbnail Image

Lifestyle Drugs - Global Strategic Business Report

  • Report
  • August 2026
  • 184 Pages
  • Global
From
Anti-Obesity Therapeutics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Anti-Obesity Therapeutics Market - Global Forecast 2026-2032

  • Report
  • August 2026
  • 187 Pages
  • Global
From
Non-invasive Fat Reduction Market - Global Forecast 2026-2032 - Product Thumbnail Image

Non-invasive Fat Reduction Market - Global Forecast 2026-2032

  • Report
  • August 2026
  • 183 Pages
  • Global
From
Obesity Treatment Market - Global Forecast 2026-2032 - Product Thumbnail Image

Obesity Treatment Market - Global Forecast 2026-2032

  • Report
  • August 2026
  • 186 Pages
  • Global
From
Loading Indicator

The Anti-Obesity Drugs market is a sector of the pharmaceutical industry that focuses on the development and sale of drugs designed to reduce or prevent obesity. These drugs are typically prescribed to individuals who are overweight or obese and are at risk of developing health complications due to their weight. Commonly prescribed anti-obesity drugs include orlistat, lorcaserin, and phentermine. These drugs work by suppressing appetite, increasing metabolism, or blocking the absorption of fat. The Anti-Obesity Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include GlaxoSmithKline, Novo Nordisk, Sanofi, Pfizer, and Merck. These companies are constantly developing new drugs and treatments to meet the needs of their customers. Show Less Read more